• 4 Posts
  • 1.31K Comments
Joined 11 months ago
cake
Cake day: July 20th, 2023

help-circle






  • Man it’s hard being a fan who genuinely dislikes a good amount of the Disney stuff for reasons other than “mouse worked my show, woke bad!”

    The ST was an unplanned, nonsensical mess which there is no excuse for given the experienced directors, money thrown at it, and IP that landed in their laps.

    Rebels was good, Resistance was a hot mess.

    Rogue One was great, still watch it on a regular basis with the OT/PT

    Solo was meh.

    First 2 seasons of Mando were great.

    Mando season 3 sucked.

    BOBF sucked.

    Kenobi sucked but seeing Alderaan was cool.

    Andor was fucking amazeballs.

    Ahsoka was ok.

    Acolyte has just been really boring so far until Ep 5, which brought some good action and story. The writing and acting still need work though.

    I don’t know what the answer is. A lot of the stories are good but they just aren’t executed very well. With Kenobi it was also the quality of the effects…like it wasn’t finished completely in post-production. I hope Ahsoka season 2 is better, and I hope they make things that you don’t have to have read 20 years of Legends to follow (even though they’re great and should be read).

    I wanna hope that things will pick up, but it’s been 10 years and idk how long they can keep just being “ok” considering the IP, the tech, the money, and the experience behind the scenes that goes into all of it.







  • It sounds like it didn’t get reviewed By the publisher and he seems genuinely apologetic.

    Miami New Times publisher Adam Simon tells Axios the ad is unacceptable and he’s changing the alt weekly’s ad review process.

    • Normally, he said, staffers — including himself — review ads prior to publication. But in this case, the ad came in past their deadline and Simon did not review it.
    • The New Times will no longer take ads so late that they can’t be reviewed, he said.
    • “Naturally, had I seen it, which I should have, I would not have let it run as is.”

    Who knows for sure, but I was expecting whoever ran the ad to either be a supporter or completely indifferent. It was a nice surprise to see them also be upset instead.


  • This is a hard one. I think we can all agree that the people who need it should have it and the people who don’t…don’t…especially if their easy access to the drug pretty much guarantees a shortage of the drug for those who do need it.

    I need it. And when there was a shortage just as we were forced to return to the office after Covid wfh, it was a nightmare. I don’t know for sure that this company was handing out prescriptions to whoever would pay or if they were mostly legitimate, but I imagine that it’s somewhere in between the two. And I do know that we will never be able to have a rational discussion about it between health professionals and the DEA/FDA, etc.

    So, a lot of people who need it won’t get it either due to shortages or due to not being able to access a prescription for whatever reason.

    Some people will continue to access it who don’t need it, but on a level that guarantees sporadic shortages for others.

    No one wins other than those profiting either by selling prescriptions or by selling the drugs themselves at a much higher price than they paid for it using said prescriptions.

    Rinse, wash, repeat.